Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

28.98
Delayed Data
As of May 24
 +0.22 / +0.76%
Today’s Change
28.06
Today|||52-Week Range
56.44
-20.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
AssetsCash7.0B1.6B987.1M897.8M
 
 
 
 
 
Short Term Investment Cash1.0B-5.5B-546.8M-90.8M
 
 
 
 
 
Cash & Short Term Investments7.0B1.6B1.7B909.7M
 
 
 
 
 
 
ReceivablesReceivables5.4B8.1B7.5B7.2B
 
 
 
 
 
 
InventoriesInventories3.9B5.4B4.9B5.0B
 
 
 
 
 
 
Current AssetsPrepaid Expenses----1.4B957.6M
 
 
 
Other Current Assets2.0B2.4B1.4B698.3M
 
 
 
 
 
Current Assets18.3B17.4B16.9B14.8B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--12.2B11.9B12.1B
 
 
 
 
Depreciation---3.9B-3.8B-4.0B
 
 
 
 
Intangible Assets30.2B69.9B65.8B66.0B
 
 
 
 
 
Other Assets32.8B71.9B66.7B67.3B
 
 
 
 
 
Total Assets57.9B98.8B92.8B91.0B
 
 
 
 
 
 
LiabilitiesAccounts Payable3.9B5.0B2.2B2.4B
 
 
 
 
 
Short Term Debt2.9B3.7B3.3B1.9B
 
 
 
 
 
Accrued Expenses--1.3B3.4B2.5B
 
 
 
 
Other Current Liabilities7.7B10.7B12.2B10.9B
 
 
 
 
 
Other Liabilities14.4B19.3B18.5B15.9B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt8.0B33.2B32.5B32.6B
 
 
 
 
 
Deferred Taxes-2.1B-6.8B-4.5B-4.5B
 
 
 
 
 
Other Liabilities1.4B1.4B1.6B1.6B
 
 
 
 
 
Total Liabilities25.9B61.7B57.8B55.4B
 
 
 
 
 
 
EquityMinority Interest-12.2M-2.0M-999.2K-4.1M
 
 
 
 
 
Preferred Stock3.6B3.6B3.6B3.6B
 
 
 
 
 
Common Equity26.5B31.5B29.7B30.3B
 
 
 
 
 
Total Shareholder Equity30.2B35.1B33.3B33.9B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding914.0M1.0B1.0B1.0B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.